Research & Treatment News
June 30, 2009
According to some investor analysts, Achillion's research and development programs (including potential Hep C solutions) make this company an ideal stock purchase.
Continue reading "HCV Research and Development Company a Promising Investment"
Posted by Editors at 4:30 PM
By enrolling Hepatitis C patients for whom treatment with combination therapy is not advised, Conatus Pharmaceuticals is testing a unique compound that inhibits the activity of matrix metalloproteinases.
Continue reading "Trial Tackling Hepatitis C With New Drug"
Posted by Editors at 3:25 PM
June 29, 2009
Ever since a Tennessee hospital disclosed that an internationally known businessman - Steve Jobs - recently received a liver transplant there, controversy has swirled around transplantation fairness.
Continue reading "Apple CEO Gets Hotly Debated Liver Transplant"
Posted by Editors at 10:45 AM
June 23, 2009
At 2009's largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery (Digestive Disease Week), substantial progress for those with liver disease, including chronic Hepatitis C, was presented.
Continue reading "Modern and Traditional Research Expands Knowledge of Liver Disease"
Posted by Editors at 11:01 AM
June 22, 2009
Although their first attempt at Hepatitis C antiviral therapy was unsuccessful, a significant number of previous non-responders achieved a sustained viral response with once-daily Infergen with Ribavirin.
Continue reading "Infergen and Ribavirin Trial Brings Renewed Hope to Previous Non-Responders"
Posted by Editors at 3:42 PM
June 17, 2009
Discover six useful tips for people with Hepatitis C who are also managing liver cirrhosis. These tips can help prevent their condition from worsening.
Continue reading "Advanced Hepatitis C Infection: Six Tips to Temper Cirrhosis"
Posted by Editors at 3:00 PM